Conclusions
addictive disorders, comorbidity, psychiatric comorbidity, psychotic disorders, SUDs
DISORDERS
Given the characteristics of its design and notwithstanding its limitations, this research can provide indicative and valuable preliminary information on the prevalence of SUD and OMD co-occurrence, and medication provided, in both the mental health and the addiction networks throughout Spain, and on the differences by gender on both issues. In general, the data obtained show a significant co-occurrence of diagnoses (in more than 60% of patients), with some differences between women and men: women are at greater risk for psychiatric comorbidity (with higher prevalence of all OMDs, except psychotic disorders). This must be considered when identifying interventional strategies because it may differ from those most beneficial for men. We found also low intervention in SUDs in mental health settings, common treatments for OMDs in addiction treatment networks, a high prescription of benzodiazepines in both networks, and certain biases related to gender related to medications prescribed and lower access to treatment services for women with this comorbidityThis study provides preliminary information on the coexistence in routine clinical practice of addictive disorders and other mental disorders in Spain, and on the treatment provided, reflecting the comorbidity in normal conditions of clinical practice and the possible distortions in how this is treated in women. In fact, it shows some differences in prevalence and clinical characteristic, and especially in treatment approaches between women and men. Thus, should be useful to adapt the treatment response with greater precision, and with a gender perspective.